Guangzhou Baiyunshan Hanfang Launches Injectable Soybean Oil Medicinal Excipient

Globally Certified, China-Sourced Solution for Stable Pharmaceutical Supply Chains

Guangzhou, China – 2026 – Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a leading Chinese provider of high-end medicinal lipid excipients, today announces its fully certified injectable soybean oil excipient, designed to address critical supply chain gaps for global pharmaceutical manufacturers. This domestically produced excipient offers a reliable alternative to imported options, featuring strict quality control, international regulatory compliance, and consistent bulk supply capabilities. The product is now available for global orders, supporting manufacturers in producing high-end injectable formulations efficiently.

Core Product Advantages & Technical Highlights

As a key solution to long-standing import dependencies in high-end medicinal excipients, Hanfang’s injectable soybean oil ensures stable, on-demand supply for pharmaceutical manufacturers, eliminating risks associated with global logistics delays or supply shortages. The product serves as an energy supplement and medicinal excipient, meeting strict purity standards required for high-end injectable formulations, supporting the production of safe, effective injectable drugs for global markets.

Global Compliance & Certifications

Hanfang’s injectable soybean oil adheres to international pharmaceutical standards, with certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. These credentials ensure the product meets regulatory requirements across Europe, North America, Asia-Pacific, and other key global markets, enabling seamless integration into manufacturers’ existing production lines.

Availability & Customization Services

The injectable soybean oil excipient is now available for global orders through Hanfang’s official website and authorized distributors worldwide. In addition to standard bulk supply, the company offers customized solutions tailored to specific manufacturer requirements, including formulation adjustments and packaging options, to support diverse pharmaceutical production needs.

Executive Quote

"Our injectable soybean oil excipient marks another milestone in breaking international monopolies in high-end medicinal excipients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "By providing a reliable, domestically produced alternative, we aim to strengthen global pharmaceutical supply chain resilience and support manufacturers in delivering high-quality injectable drugs to patients worldwide."

Industry Context & Strategic Focus

For decades, high-end medicinal lipid excipients like injectable soybean oil have been dominated by international suppliers, creating supply chain vulnerabilities for global pharmaceutical manufacturers. Hanfang’s launch addresses this gap by leveraging its state-of-the-art R&D and production capabilities to deliver a cost-effective, compliant alternative aligned with global industry demands.

Future Plans

Looking ahead, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. will continue to invest in R&D for high-end medicinal excipients, expanding its product portfolio to meet evolving global pharmaceutical needs. The company also plans to enhance its global distribution network, ensuring timely, localized support for clients across more than 20 countries and regions.

About Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.

Founded in 1998, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a state-owned enterprise under the Guangzhou Pharmaceutical Holdings Group, specializing in high-end medicinal lipid excipients, specialty anti-tumor APIs, and Ganoderma health products. The company operates the only national-level engineering research center for traditional Chinese medicine pharmaceutical technology, holds over 240 patents, and has received honors including National Green Factory and National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise. Its products are sold in more than 20 countries and regions, serving over 1,000 clients including global pharmaceutical leaders like B. Braun and AstraZeneca.

Contact Information

Company: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. Official Website: http://byshanhanfang.com/.

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved.